- STAT+: J&J spends $1 billion to enter KRAS race for cancer treatmentsJohnson & Johnson said it will purchase the startup Firefly Bio for $1 billion in an effort to expand its work in the suddenly buzzy field of KRAS inhibitors.STAT · 1mo ago↗ source
- Major readouts from the annual diabetes conferenceWhy "Schedule F" matters, the Ebola outbreak response, and more health news from Morning RoundsSTAT · 1mo ago↗ source
- STAT+: Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rateA combination of pancreatic cancer drugs from Tango Therapeutics and Revolution Medicines led to a strong response rate in an early-stage trial.STAT · 1mo ago↗ source